Synteract Presents and Participates in Industry Conferences to Continue Engaging on Key Clinical Development Topics

RESEARCH TRIANGLE PARK, NC– Sept. 27, 2019 – Synteract, an innovative contract research organization partnering with biotech and pharma companies to bring new medicines to market, continues to engage globally with innovative drug developers through participation in multiple industry conferences this October. Synteract’s leaders will address current therapeutic, regulatory and strategic trends and topics impacting clinical development today.

Attendees are invited to come meet with Synteract at any of these upcoming events:

• October 2-3: Outsourcing in Clinical Trials New England – Boston – Booth #53 –
  Derek Ansel, CCRA, Director, Rare & Orphan Diseases, will speak on Key Considerations For Optimizing Clinical Trials in Rare Disease and Specialized Patient Populations, Oct. 3^rd at 11:30 a.m.
  
• October 9-13: EADV Congress – Madrid, Spain – Booth #D9 – Synteract will showcase its Center of Development in Dermatology at this 28^th annual meeting addressing the latest advances and trending topics in dermatology.
• October 9-10: Outsourcing in Clinical Trials DACH – Munich – Booth #26 – Executive Director of Regulatory Affairs Ludwig Baumann will speak on Oct. 9^th at 9:30 a.m. on Key Regulatory Considerations to Optimize Study Start-up.
• October 11: Clinical Trials Symposium in Bucharest, Romania – Our VP for Pediatric Development Dr. Martine Dehlinger-Kremer will present on Changes in the Drug Development Landscape: Pediatric Development is No Longer an Option.
• October 16: 1^st Panhellenic Congress on Clinical Trials & Research – Athens – Synteract regulatory and clinical professionals will attend this first ever Greek conference focused on appropriate policies for clinical trials.
• October 20-23: American Conference on Pharmacometrics – Orlando, FL – Booth #13 – our PKPD experts will attend this scientific meeting to share Synteract’s expertise in pharmacometrics and how modeling and simulation can support clinical trials.
• October 26-29: American College of Clinical Pharmacology – NY, NY – Synteract’s PKPD experts will attend this annual meeting to share their Juvenile Toxicology and Formulation Consulting experience, as well as PKPD expertise

To meet with the Synteract team at any of these upcoming events, email Kate.Mullis@synteract.com. For more information on these or other upcoming conferences and webinars, visit our events page on Synteract.com.

About Synteract

“Bringing Clinical Trials to Life” represents Synteract’s commitment to engage with drug developers, patients, investigators, and regulatory experts, to bring insights to action and make better therapies a reality. Synteract supports biotech and pharma companies across all phases of drug development to help bring new medicines to market. Synteract has conducted nearly 4,000 studies on six continents and in more than 60 countries. It has contributed to more than 240 product approvals. Synteract offers a notable depth of expertise in oncology, general medicine, dermatology, neuroscience, pediatrics, and rare and orphan diseases. Connect on LinkedIn and Twitter.

# # #